SAN DIEGO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC ID: RGBP and RGBPP) today provided further insight into its planned Phase 1 clinical trial of HemaXellerate, the company’s innovative stem cell-derived therapy, which has already received U.S. FDA clearance. While the initial focus is on treating aplastic anemia, a rare orphan indication, Regen BioPharma is evaluating expanded applications for this groundbreaking therapy in markets poised for significant growth.
THOMASVILLE, Ga., Aug. 15, 2025 /PRNewswire/ -- Flowers Foods, Inc. (NYSE: FLO) today reported financial results for the company's 12-week second quarter ended July 12, 2025.
...
HONG KONG, Aug. 15, 2025 (GLOBE NEWSWIRE) -- CoinEx, a leading cryptocurrency exchange, will once again make a strong appearance at Coinfest Asia 2025, Southeast Asia’s premier crypto and Web3 festival. CoinEx, as a sponsor of the event, continues to sponsor and connect with global innovators and investors to explore the future of the crypto industry.
The outlook for the neuroblastoma treatment market is optimistic, fueled by progress in targeted therapies and immunotherapies. GD2-targeted immunotherapy is increasingly being incorporated into...
The outlook for the neuroblastoma treatment market is optimistic, fueled by progress in targeted therapies and immunotherapies. GD2-targeted immunotherapy is increasingly being incorporated into...
NICOSIA, Cyprus, Aug. 14, 2025 /PRNewswire/ -- Bookmap, a market-leading platform for order flow and liquidity visualization, has partnered with Tradier to offer futures...
LOS ANGELES, Aug. 14, 2025 /PRNewswire/ -- Lido Advisors, a fast-growing national wealth advisory firm with more than $30 billion in RAUM*, today announced...
Will focus on high-performance solutions for new construction and rehabilitation projects
NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Bright Power has announced a change in its...
VANCOUVER, BC, Aug. 14, 2025 /CNW/ - Metallis Resources Inc. (TSX-V: MTS; OTCQB: MTLFF) Metallis Resources Inc. (the "Company" or "Metallis") is pleased to...
Integrated into Cortellis Regulatory Intelligence, new AI capability helps regulatory teams streamline access to critical intelligence and understand requirements with ease
LONDON, Aug. 14, 2025...
New platform boosts patient experience and safety, reduces clinician burden, and unlocks operational insight across inpatient mental health hospitals
SYDNEY, Aug. 13, 2025 /PRNewswire/ --...